drugset / Trial / NCT00021736
Phase II/III Study of Anti-VEGF in Neovascular AMD
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether the anti-VEGF drug is effective at stabilizing and/or improving vision in patients with the wet form of AMD
Timeline
- Start
- 2001-07
- Primary completion
- —
- Completion
- 2002-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegaptanib sodium | Aptamer | — | Intravitreal |